drugset / Trial / NCT00002277

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NCT00002277

Phase 3 Completed Pfizer
Treatment

Summary

To compare the safety, tolerance and efficacy of fluconazole and amphotericin B as treatment for biopsy proven fungal infections in major organs, disseminated infection, suspected fungal infection and fungemia in adult neutropenic and non-neutropenic patients without AIDS, AIDS related complex (ARC), or extensive burns. HIV seropositive patients are allowed only if they also have a malignancy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown
Subject Fluconazole Small molecule